Robert Horne
Rob Horne is Professor of Behavioural Medicine at University College London. His research focuses on the role of psychological and behavioural factors in explaining variation in response to treatment.
Rob trained in pharmacy and health psychology. A key theme in his research is the understanding of patient and public perspectives of illness and treatment and how this can be applied to help get the best from essential treatments for the benefit of individuals and society.
He has developed a series of internationally applied frameworks and tools for supporting treatment engagement and adherence and enhancing patient care including the Perceptions & Practicalities Approach (PaPA) and Necessity Concerns Framework (NCF), which form the basis for the NICE Guidelines for Medicines Adherence.
He has over 300 peer-reviewed publications (>39,000 citations H-index 91) supported by grants of over £30 million (£4.9 million as Principal Investigator) in the last decade. He is a Fellow of the Royal Pharmaceutical Society and Fellow of the Royal College of Physicians, Faculty of Pharmaceutical Medicine. He is founding Director of Spoonful of Sugar Ltd, a UCL Business company working globally with industry partners healthcare providers and third sector organisations to implement his research into practice.
-
Robert Horne
Bands:
A Less than 2% of gross annual income
B Between 2% and 10% of gross annual income
C Any payment between 10% and 20% of gross annual income
D Any payment over 20% of your gross annual incomeAll interests declared are for the previous calendar year
Section 1: Paid Work / Personal Income
A. Employments (including partnerships)
B. Other paid positions / work
C. Other income
D. Other personal benefits
I have not received hospitality/travel grants from pharmaceutical companies to attend conferences/meetingsSection 2: Unpaid Work
A. Trusteeships / Directorships (unpaid)
B. Other unpaid / voluntary work
Do you hold any other significant positions that may create a conflicting interest to PCRS?Section 3: Shareholdings in relevant companies
Pharmaceutical Companies
Section 4: Other Non-personal Interests
Section 5: Interests of Spouses / Long Term Partners and Children